Hugo Diniz, MD 🇵🇹 🇪🇺 (@hdiniz_) 's Twitter Profile
Hugo Diniz, MD 🇵🇹 🇪🇺

@hdiniz_

Diagnostic & Interventional Nephrologist @chusaojoao | #POCUS enthusiast |
@ynptweets Board | @erakidney #SoMe | #NSMC

ID: 2843403507

linkhttps://www.researchgate.net/profile/Hugo_Diniz4 calendar_today25-10-2014 09:34:31

3,3K Tweet

1,1K Followers

728 Following

ERA - European Renal Association (@erakidney) 's Twitter Profile Photo

✨ Highlights from Dr. Vittoria Arditto 💊 Drug approval and reimbursement in the EU can take years, delaying patient access even after EMA approval. ⚖️ Cause: Misalignment between EMA requirements and national organisations approval processes. 🔍 Solution:Real-World Data

✨ Highlights from Dr. Vittoria Arditto
💊 Drug approval and reimbursement in the EU can take years, delaying patient access even after EMA approval.

⚖️ Cause: Misalignment between EMA requirements and national organisations approval processes.

 🔍 Solution:Real-World Data
ERA - European Renal Association (@erakidney) 's Twitter Profile Photo

✨ Highlights from Prof. Christof Wanner: 🔬 RCTs are still needed to provide the base for guidelines 💸 Obtaining RWD does not go without cost 🔍 Data in RWDatabases sometimes lack granularity 🤝 We should pursuit a stake-holder colaborative approach Signing off, on behalf of

✨ Highlights from Prof. Christof Wanner:
🔬 RCTs are still needed to provide the base for guidelines
💸 Obtaining RWD does not go without cost
🔍 Data in RWDatabases sometimes lack granularity
🤝 We should pursuit a stake-holder colaborative approach

Signing off, on behalf of
Brendon Neuen (@brendonneuen) 's Twitter Profile Photo

Inside story from Rajiv Agarwal MD, MS: #CONFIDENCE done in 2 parts because of early safety concerns re simultaneous SGLT2i & nsMRA 🔹 Part A: higher GFR with ABPM after first dose 🔹 Part B: Main study without ABPM after 👍 from DSMB hcplive.com/view/kidney-co… #KidneyCompass #ERA25

ERA - European Renal Association (@erakidney) 's Twitter Profile Photo

The long-term effect of marine n-3 polyunsaturated fatty acid supplementation in kidney transplantation: A randomized controlled trial - Joe Chan (Norway) Here is all the ☕️ for this final morning of the #ERA25 Always #BeyondNephrology by Raquel Barba Teba 🦋

ERA - European Renal Association (@erakidney) 's Twitter Profile Photo

#ERA25 Game Changers in cAMR session chaired by Rainer Oberbauer & Dr Christophe Mariat. Highlight: Dr Tristan de Nattes on Anti-CD38 therapy in AMR – promising frontier in tackling chronic rejection. #TransplantNephrology #AMR #cAMR #NephTwitter

#ERA25 Game Changers in cAMR session chaired by <a href="/RainerOberbauer/">Rainer Oberbauer</a> &amp; Dr Christophe Mariat.

Highlight: Dr Tristan de Nattes on Anti-CD38 therapy in AMR – promising frontier in tackling chronic rejection.
#TransplantNephrology #AMR #cAMR #NephTwitter
ERA - European Renal Association (@erakidney) 's Twitter Profile Photo

Simultaneous publication in Circulation during the last day of #ERA25 📍NUDGE-CKD trial: interesting methodology that can be embeded and adapted into ant least types of universal healthcare sys, and maybe not only if you want to know more see the 🔗 ahajournals.org/doi/abs/10.116…

ERA - European Renal Association (@erakidney) 's Twitter Profile Photo

Navigating IgAN Management in the Era of new KDIGO Guidelines 🔎 👤 Jonathan Barratt Jonathan Barratt 👤 Jürgen Floege 👤 Lucia Del Vecchio 👤 Chair, Christoph Wanner Christoph Wanner

ERA - European Renal Association (@erakidney) 's Twitter Profile Photo

❗️Check out the latest game changers in IgA Nephropathy: 📣 Several innovative and promising therapies for IgA Nephropathy are emerging: 💥 B-cell targeting therapies: Anti-APRIL and BAFF inhibitors show promise in reducing immunoglobulin production 💥 Endothelin receptor

❗️Check out the latest game changers in IgA Nephropathy:
📣 Several innovative and promising therapies for IgA Nephropathy are emerging:
💥 B-cell targeting therapies: Anti-APRIL and BAFF inhibitors show promise in reducing immunoglobulin production
💥 Endothelin receptor
Wisit Cheungpasitporn MD FACP | FASN | FAST (@wisit661) 's Twitter Profile Photo

🌟 Honored to present “Generative AI and Chatbot Application in Critical Care Nephrology” at the 43rd Vicenza Course – AKI-CRRT-EBPT in June 2025 🇮🇹 😃VicenzaCourse This was a transformative opportunity to share how Generative #AI is reshaping critical care nephrology—from

🌟 Honored to present “Generative AI and Chatbot Application in Critical Care Nephrology” at the 43rd Vicenza Course – AKI-CRRT-EBPT in June 2025 🇮🇹 😃<a href="/VicenzaCourse/">VicenzaCourse</a> 

This was a transformative opportunity to share how Generative #AI is reshaping critical care nephrology—from
ERA - European Renal Association (@erakidney) 's Twitter Profile Photo

📢 Join us at the WG e-seminar organised by G&K and YNP: *Clinical evaluation of individuals who may have a genetic kidney disease: the importance of deep-phenotyping* 📅 July 8, 2025 at 5:00 PM (CEST) ERA Members can earn ECMEC® credits by participating live! 🆕The live

📢 Join us at the WG e-seminar organised by G&amp;K and YNP: *Clinical evaluation of individuals who may have a genetic kidney disease: the importance of deep-phenotyping*
📅 July 8, 2025 at 5:00 PM (CEST)
ERA Members can earn ECMEC® credits by participating live!
🆕The live